Kaman Reports 2019 Fourth Quarter and Full Year Results

February 24, 2020

 

Fourth Quarter Highlights from Continuing Operations:

  • Net sales up 7.7% to $237.8 million versus prior year
  • Aerospace operating income increased 7.9% to $45.0 million, or 18.9% of sales
  • Net earnings increased $18.5 million to $34.1 million
  • Diluted earnings per share rose $0.66 to $1.22, or $0.80 adjusted*

Full Year Highlights from Continuing Operations:

  • Net sales up 3.5% to $761.6 million versus prior year
  • Aerospace operating margin up 430 basis points to 17.1%, or 17.2% adjusted*
  • Diluted earnings per share $2.01, or $1.63 adjusted*
  • Record JPF deliveries of 41,429 units
  • Record order intake for specialty bearing and engineered products

Kaman Corp. (NYSE:KAMN) today reported financial results for the fourth fiscal quarter ended December 31, 2019.

 

 

 

 

 

 

 

Table 1. Summary of Financial Results (unaudited)

 

 

 

 

 

In thousands except per share amounts

For the Three Months Ended

 

 

December 31, 2019

 

December 31, 2018

 

Change

 

 

 

 

 

 

 

 

Net sales from continuing operations

$

237,792

 

 

$

220,859

 

 

$

16,933

 

 

Operating income from continuing operations:

 

 

 

 

 

 

Aerospace

$

45,041

 

 

$

41,748

 

 

$

3,293

 

 

% of sales

18.9

%

 

18.9

%

 

%

 

Loss on sale of business

(3,739

)

 

(5,722

)

 

1,983

 

 

Net gain (loss) on sale of assets

114

 

 

(528

)

 

642

 

 

Corporate expense

(26,576

)

 

(11,379

)

 

(15,197

)

 

Operating income from continuing operations

$

14,840

 

 

$

24,119

 

 

$

(9,279

)

 

Adjusted EBITDA*:

 

 

 

 

 

 

Earnings from continuing operations

$

34,105

 

 

$

15,632

 

 

$

18,473

 

 

Adjustments

2,641

 

 

26,098

 

 

(23,457

)

 

Adjusted EBITDA*

$

36,746

 

 

$

41,730

 

 

$

(4,984

)

 

% of sales

15.5

%

 

18.9

%

 

(3.4

)%

 

Earnings per share:

 

 

 

 

 

 

Diluted earnings per share from continuing operations

$

1.22

 

 

$

0.56

 

 

$

0.66

 

 

Adjustments

(0.42

)

 

0.33

 

 

(0.75

)

 

Adjusted diluted earnings per share from continuing operations*

$

0.80

 

 

$

0.89

 

 

$

(0.09

)

 

 

 

         

Neal J. Keating, Chairman, President and Chief Executive Officer, commented, “We ended 2019 with strong fourth quarter results. Sales for the quarter increased 7.7% to $237.8 million and the mix was weighted toward our higher margin products resulting in Aerospace operating margin of 18.9%, or 19.0% adjusted*. These results helped us to achieve the high end of our outlook for the year, with full year Aerospace operating margin of 17.1%, or 17.2% adjusted*. The planning and execution of our team allowed us to deliver a record 41,429 joint programmable fuzes in the year, and with JPF backlog of $356.8 million at year end, we expect record delivery levels again in 2020. We also saw record sales and orders for our specialty bearings products in 2019, led by our self-lubricating bearings. While we anticipate the grounding of Boeing’s 737MAX to impact our results in 2020, we expect to more than offset this impact with growth across our other specialty bearing and engineered products based on the increased order rates, which continued into 2020, and current backlog.

During the fourth quarter, we took initial steps towards reducing our general and administrative expenses and we remain focused on achieving our previously stated goal of reducing G&A expense across the organization near the high end of our estimated $15 million to $20 million range exiting 2020.

On January 3rd we closed the acquisition of Bal Seal Engineering. We welcome the Bal Seal employees to the Kaman family and look forward to the continued success of this business under our ownership. With the completion of this transaction and the integration of the operations underway, we are focused on continuing to deploy the capital we received from the sale of our distribution business. We end the year with more than $700 million of available cash and debt capacity and we are well positioned to execute on our long-term growth strategy of expanding our highly engineered product offerings. As we look to 2020, we expect top line organic growth, complemented by the addition of Bal Seal. Additionally, we will build off of our efforts in 2019 and continue the transformation of Kaman into a manufacturer of highly engineered products and components serving aerospace and defense, medical, and industrial markets."

Chief Financial Officer,
Robert D. Starr, commented, "Cash flows provided by continuing operations of $42.5 million led to Free Cash Flow from continuing operations* for the year of $20.0 million. Impacting cash flow for the period was the significant sales ramp in the fourth quarter and the shift in timing of cash receipt for JPF DCS sales into 2020. Diluted earnings per share from continuing operations for the quarter was $1.22, or $0.80* when adjusted for the expense associated with our acquisition of Bal Seal, certain restructuring and corporate development expenses, and several other tax related items."

2020 Outlook

(in millions)

2019

 

2020 Outlook

 

Actual

 

Low End

 

High End

Sales from continuing operations

$

761.6

 

$

860.0

 

$

880.0

 

 

 

 

 

 

Operating Margins

 

 

 

 

 

Operating margin from continuing operations

7.0%

 

5.0%

 

6.7%

Operating margin impact of adjustments

2.6%

 

5.0%

 

4.8%

Operating margin from continuing operations, adjusted*

9.6%

 

10.0%

 

11.5%

 

 

 

 

 

 

Adjusted EBITDA

 

 

 

 

 

Earnings from continuing operations

$

56.4

 

$

38.5

 

$

50.5

Adjustments

$

42.9

 

$

82.2

 

$

85.8

Adjusted EBITDA* from continuing operations

$

99.3

 

$

120.7

 

$

136.3

Adjusted EBITDA margin* from continuing operations

13.0%

 

14.0%

 

15.5%

 

 

 

 

 

 

Free Cash Flow

 

 

 

 

 

Operating cash flow from continuing operations

$

42.5

 

$

85.0

 

$

95.0

Cash used for the purchase of property, plant and equipment

$

(22.5)

 

$

(25.0)

 

$

(25.0)

Free Cash Flow* from continuing operations

$

20.0

 

$

60.0

 

$

70.0

Commenting on the 2020 outlook,
Mr. Starr stated, "We expect sales in the range of $860.0 to $880.0 million. We anticipate organic sales growth of 1.0% to 3.0%, despite the headwinds from 737MAX, and we expect Bal Seal to contribute approximately $95.0 million to our top line performance for the year. Consolidated operating margins of 5.0% to 6.7% will include costs related to the purchase accounting for Bal Seal of $32.0 million and costs related to our expense reduction efforts, corporate development activities, and transition services agreement totaling $10.3 million. Adjusted for these items, we expect consolidated operating margins in the range of 10.0% to 11.5%*. With depreciation and amortization expense of approximately $35 million, we expect to deliver Adjusted EBITDA margin* at the consolidated level in the range of 14.0% to 15.5%, a 175 basis point increase at the mid-point over our Adjusted EBITDA margin* for 2019. This anticipated improvement in Adjusted EBITDA margin* is due to the expected sales mix in the year, the addition of higher margin sales from Bal Seal, improved performance from our structures programs, and the partial benefit from our cost reduction efforts.

Finally, we expect earnings for 2020 to be weighted toward the second half of the year. Approximately 65% of our earnings will occur in the second half of the year, consistent with our earnings pattern in recent years."

Additional Financial Information

  • Expenses associated with the purchase accounting of Bal Seal of approximately $32 million
  • Depreciation and amortization expense of approximately $35 million
  • Net periodic pension benefit of approximately $16.5 million
  • Interest expense of approximately $15.0 million
  • Estimated annualized tax rate of 23.0%

Please see the MD&A section of the Company's Form 10-K filed with the Securities and Exchange Commission concurrently with the issuance of this release for greater detail on our results and various company programs.

A conference call has been scheduled for tomorrow, February 25, 2020, at 8:30 AM ET. Listeners may access the call live by telephone at (844) 473-0975 and from outside theU.S.at (562) 350-0826 using the Conference ID: 8789822; or, via the Internet atwww.kaman.com. A replay will also be available two hours after the call and can be accessed at (855) 859-2056 or (404) 537-3406 using the Conference ID: 8789822. In its discussion, management may reference certain non-GAAP financial measures related to company performance. A reconciliation of that information to the most directly comparable GAAP measures is provided in this release.

About Kaman Corporation

Kaman Corporation, founded in 1945 by aviation pioneer
Charles H. Kaman, and headquartered in Bloomfield, Connecticut, conducts business in the aerospace & defense, industrial and medical markets. Kaman produces and markets proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft; safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of our SH-2G Super Seasprite maritime helicopters; manufacture and support of our K-MAX® manned and unmanned medium-to-heavy lift helicopters.

More information is available at www.kaman.com.

Table 2. Summary of Segment Information

(in thousands)

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Net sales from continuing operations

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

 

 

 

 

 

 

 

 

 

Operating income from continuing operations:

 

 

 

 

 

 

 

 

Aerospace

 

$

45,041

 

 

$

41,748

 

 

$

130,393

 

 

$

94,357

 

Loss on sale of business

 

(3,739

)

 

(5,722

)

 

(3,739

)

 

(5,722

)

Net gain (loss) on sale of assets

 

114

 

 

(528

)

 

(237

)

 

1,031

 

Corporate expense

 

(26,576

)

 

(11,379

)

 

(73,006

)

 

(56,703

)

Operating income from continuing operations

 

$

14,840

 

 

$

24,119

 

 

$

53,411

 

 

$

32,963

 

Table 3. Depreciation and Amortization from continuing operations (in thousands)

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Depreciation and Amortization:

 

 

 

 

 

 

 

 

Aerospace

 

$

5,766

 

 

$

5,945

 

 

$

22,697

 

 

$

24,506

 

Corporate

 

780

 

 

850

 

 

3,157

 

 

3,369

 

Consolidated Total

 

$

6,546

 

 

$

6,795

 

 

$

25,854

 

 

$

27,875

 

Non-GAAP Measures Disclosure

Management believes that the Non-GAAP financial measures (i.e. financial measures that are not computed in accordance with Generally Accepted Accounting Principles) identified by an asterisk (*) used in this release or in other disclosures provide important perspectives into the Company's ongoing business performance. The Company does not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the Non-GAAP measures used in this release and other disclosures as follows:

Organic Sales - Organic Sales is defined as "
Net Sales" less sales derived from acquisitions completed during the preceding twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, which can obscure underlying trends. We also believe that presenting Organic Sales enables a more direct comparison to other businesses and companies in similar industries. Management recognizes that the term "Organic Sales" may be interpreted differently by other companies and under different circumstances. No other adjustments were made during the three-month and twelve-month fiscal periods ended December 31, 2019 and December 31, 2018, respectively. The following table illustrates the calculation of Organic Sales using the GAAP measure, "
Net Sales".

Organic Sales from continuing operations (in thousands)

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Net sales

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

Acquisition Sales

 

 

 

 

 

 

 

 

Organic Sales

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

Adjusted EBITDA from continuing operations - Adjusted EBITDA from continuing operations is defined as earnings from continuing operations before interest, taxes, other expense (income), net, depreciation and amortization and certain items that are not indicative of the operating performance of the Company's for the period presented. Adjusted EBITDA from continuing operations differs from earnings from continuing operations, as calculated in accordance with GAAP, in that it excludes interest expense, net, income tax expense, depreciation and amortization, other expense (income), net, non-service pension and post retirement benefit expense (income), and certain items that are not indicative of the operating performance of the Company for the period presented. We have made numerous investments in our business, such as acquisitions and capital expenditures, including facility improvements, new machinery and equipment, improvements to our information technology infrastructure and ERP systems, which we have adjusted for in Adjusted EBITDA from continuing operations. Adjusted EBITDA from continuing operations also does not give effect to cash used for debt service requirements and thus does not reflect funds available for distributions, reinvestments or other discretionary uses. Management believes Adjusted EBITDA from continuing operations provides an additional perspective on the operating results of the organization and its earnings capacity and helps improve the comparability of our results between periods because it provides a view of our operations that excludes items that management believes are not reflective of operating performance, such as items traditionally removed from net earnings in the calculation of EBITDA as well as Other expense (income), net and certain items that are not indicative of the operating performance of the Company for the period presented. Adjusted EBITDA from continuing operations is not presented as an alternative measure of operating performance, as determined in accordance with GAAP. No other adjustments were made during the three-month and twelve-month fiscal periods ended December 31, 2019 and December 31, 2018. The following table illustrates the calculation of Adjusted EBITDA from continuing operations using GAAP measures:

Adjusted EBITDA from continuing operations (in thousands)

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Adjusted EBITDA from continuing operations

 

 

 

 

 

 

 

 

Consolidated Results

 

 

 

 

 

 

 

 

Sales from continuing operations

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

 

 

 

 

 

 

 

 

 

Earnings from continuing operations, net of tax

 

$

34,105

 

 

$

15,632

 

 

$

56,446

 

 

$

15,877

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

2,607

 

 

4,639

 

 

17,202

 

 

20,046

 

Income tax (benefit) expense

 

(19,103

)

 

6,883

 

 

(15,859

)

 

9,259

 

Non-service pension and post retirement benefit income

 

(98

)

 

(3,084

)

 

(396

)

 

(12,127

)

Other expense (income), net

 

58

 

 

49

 

 

(309

)

 

(92

)

Depreciation and amortization

 

6,546

 

 

6,795

 

 

25,854

 

 

27,875

 

Other Adjustments:

 

 

 

 

 

 

 

 

Restructuring and severance costs

 

1,005

 

 

2,642

 

 

1,558

 

 

7,353

 

Non-cash intangible asset impairment charge

 

 

 

 

 

 

 

10,039

 

Non-cash write-off of inventory

 

 

 

 

 

 

 

709

 

Employee tax-related matters in foreign operations

 

 

 

1,761

 

 

 

 

3,040

 

Cost associated with corporate development activities

 

7,097

 

 

30

 

 

10,090

 

 

1,081

 

Costs from transition services agreement

 

3,519

 

 

 

 

4,673

 

 

 

Income from transition services agreement

 

(2,729

)

 

 

 

(3,673

)

 

 

Loss on sale of U.K. Tooling business

 

3,739

 

 

5,722

 

 

3,739

 

 

5,722

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

661

 

 

 

 

661

 

Gain on the sale of land

 

 

 

 

 

 

 

(1,520

)

Adjustments

 

$

2,641

 

 

$

26,098

 

 

$

42,879

 

 

$

72,046

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA from continuing operations

 

$

36,746

 

 

$

41,730

 

 

$

99,325

 

 

$

87,923

 

Adjusted EBITDA margin

 

15.5

%

 

18.9

%

 

13.0

%

 

11.9

%

Outlook - Adjusted EBITDA from continuing operations (in millions)

 

 

 

 

 

 

 

2020 Outlook

 

 

 

Low

 

High

Adjusted EBITDA from continuing operations

 

 

 

 

 

2020 Outlook

 

 

 

 

 

Sales from continuing operations

 

 

$

860.0

 

 

$

880.0

 

 

 

 

 

 

 

Earnings from continuing operations, net of tax

 

 

$

38.5

 

 

$

50.5

 

 

 

 

 

 

 

Interest expense, net

 

 

15.0

 

 

15.0

 

Income tax (benefit) expense

 

 

11.5

 

 

15.1

 

Net Periodic Pension Benefit

 

 

(16.5

)

 

(16.5

)

Other expense (income), net

 

 

1.5

 

 

1.5

 

Depreciation and amortization

 

 

35.0

 

 

35.0

 

Other Adjustments:

 

 

 

 

 

Bal Seal Purchase Accounting - Inventory Step-up

 

 

9.2

 

 

9.2

 

Bal Seal Purchase Accounting - Compensation Expense

 

 

22.8

 

 

22.8

 

Cost associated with corporate development activities

 

 

1.5

 

 

1.5

 

Costs from transition services agreement, net of income received

 

 

2.2

 

 

2.2

 

Total Adjustments

 

 

$

82.2

 

 

$

85.8

 

 

 

 

 

 

 

Adjusted EBITDA from continuing operations

 

 

$

120.7

 

 

$

136.3

 

Adjusted EBITDA margin

 

 

14.0

%

 

15.5

%

Free Cash Flow from continuing operations - Free Cash Flow from continuing operations is defined as GAAP “Net cash provided by (used in) operating activities from continuing operations” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes Free Cash Flow from continuing operations provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow from continuing operations should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses Free Cash Flow from continuing operations internally to assess overall liquidity. The following table illustrates the calculation of Free Cash Flow from continuing operations using “Net cash provided by (used in) operating activities from continuing operations” and “Expenditures for property, plant & equipment”, GAAP measures from the Condensed Consolidated Statements of Cash Flows included in this release.

Free Cash Flow from continuing operations (in thousands)

 

 

 

 

 

 

 

 

For the Twelve
Months Ended

 

For the Nine
Months Ended

 

For the Three
Months Ended

 

 

December 31,
2019

 

September 27,
2019

 

December 31,
2019

Net cash provided by operating activities from continuing
operations

 

$

42,488

 

 

$

11,336

 

 

$

31,152

 

Expenditures for property, plant & equipment

 

(22,447

)

 

(17,411

)

 

(5,036

)

Free Cash Flow from continuing operations

 

$

20,041

 

 

$

(6,075

)

 

$

26,116

 

Debt to Capitalization Ratio - Debt to Capitalization Ratio is calculated by dividing debt by capitalization. Debt is defined as GAAP “Current portion of long-term debt” plus “Long-term debt, excluding current portion”. Capitalization is defined as Debt plus GAAP “Total shareholders' equity”. Management believes that Debt to Capitalization Ratio is a measurement of financial leverage and provides an insight into the financial structure of the Company and its financial strength. The following table illustrates the calculation of Debt to Capitalization Ratio using GAAP measures from the Condensed Consolidated Balance Sheets included in this release.

Debt to Capitalization Ratio (in thousands) (unaudited)

 

 

 

 

 

 

December 31, 2019

 

December 31, 2018

Current portion of long-term debt

 

$

 

 

$

9,375

 

Long-term debt, excluding current portion

 

181,622

 

 

284,256

 

Debt

 

$

181,622

 

 

$

293,631

 

Total shareholders' equity

 

823,202

 

 

633,157

 

Capitalization

 

$

1,004,824

 

 

$

926,788

 

Debt to Capitalization Ratio

 

18.1

%

 

31.7

%

Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings Per Share from Continuing Operations - Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings per Share from Continuing Operations are defined as GAAP "Earnings from Continuing Operations" and "Diluted earnings per share from continuing operations", less items that are not indicative of the operating performance of the business for the periods presented. These items are included in the reconciliation below. Management uses Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings per Share from Continuing Operations to evaluate performance period over period, to analyze the underlying trends in our business and to assess its performance relative to its competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance.

The following table illustrates the calculation of Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings per Share from Continuing Operations using “Earnings from Continuing Operations” and “Diluted earnings per share from continuing operations” from the “Consolidated Statements of Operations” included in the Company's Form 10-K filed with the Securities and Exchange Commission on February 24, 2020.

Adjusted Earnings from continuing operations and Adjusted Diluted Earnings per Share from continuing operations

(In thousands except per share amounts) (unaudited)

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Adjustments to Earnings from Continuing Operations

 

 

 

 

 

 

 

 

 

 

Restructuring and severance costs

 

$

1,005

 

 

$

2,642

 

 

$

1,558

 

 

$

7,353

 

Costs associated with corporate development activities

 

7,097

 

 

30

 

 

10,090

 

 

1,081

 

Loss on sale of U.K. Tooling business

 

3,739

 

 

5,722

 

 

3,739

 

 

5,722

 

Costs from transition services agreement

 

3,519

 

 

 

 

4,673

 

 

 

Income from transition services agreement

 

(2,729

)

 

 

 

(3,673

)

 

 

Tax benefit from change in state tax laws

 

 

 

 

 

(2,137

)

 

 

Tax benefit of foreign derived income included in
discontinued operations

 

3,360

 

 

 

 

3,360

 

 

 

Tax benefit from change in U.K. entity tax
classification

 

(25,710

)

 

 

 

(25,710

)

 

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

10,039

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

709

 

Employee tax-related matters in foreign operations

 

 

 

1,761

 

 

 

 

3,040

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

661

 

 

 

 

661

 

Gain on the sale of land

 

 

 

 

 

 

 

(1,520

)

Adjustments, pre tax

 

$

(9,719

)

 

$

10,816

 

 

$

(8,100

)

 

$

27,085

 

 

 

 

 

 

 

 

 

 

 

 

Tax Effect of Adjustments to Earnings from Continuing
Operations

 

 

 

 

 

 

 

 

 

 

Restructuring and severance costs

 

$

212

 

 

$

808

 

 

$

328

 

 

$

2,706

 

Costs associated with corporate development activities

 

1,496

 

 

9

 

 

2,124

 

 

398

 

Loss on sale of U.K. Tooling business

 

 

 

 

 

 

 

 

Costs from transition services agreement

 

742

 

 

 

 

984

 

 

 

Income from transition services agreement

 

(575

)

 

 

 

(773

)

 

 

Tax benefit from change in state tax laws

 

 

 

 

 

 

 

 

Tax benefit of foreign derived income included in
discontinued operations

 

 

 

 

 

 

 

 

U.K. entity classification election for tax purposes

 

 

 

 

 

 

 

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

 

Employee tax-related matters in foreign operations

 

 

 

538

 

 

 

 

1,119

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

202

 

 

 

 

243

 

Gain on the sale of land

 

 

 

 

 

 

 

(559

)

Tax effect of Adjustments

 

$

1,875

 

 

$

1,557

 

 

$

2,663

 

 

$

3,907

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments to Earnings from Continuing Operations,
net of tax

 

 

 

 

 

 

 

 

 

 

GAAP Earnings from continuing operations, as
reported

 

$

34,105

 

 

$

15,632

 

 

$

56,446

 

 

$

15,877

 

Restructuring and severance costs

 

793

 

 

1,834

 

 

1,230

 

 

4,647

 

Costs associated with corporate development activities

 

5,601

 

 

21

 

 

7,966

 

 

683

 

Loss on sale of U.K. Tooling business

 

3,739

 

 

5,722

 

 

3,739

 

 

5,722

 

Costs from transition services agreement

 

2,777

 

 

 

 

3,689

 

 

 

Income from transition services agreement

 

(2,154

)

 

 

 

(2,900

)

 

 

Tax benefit from change in state tax laws

 

 

 

 

 

(2,137

)

 

 

Tax benefit of foreign derived income included in
discontinued operations

 

3,360

 

 

 

 

3,360

 

 

 

U.K. entity classification election for tax purposes

 

(25,710

)

 

 

 

(25,710

)

 

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

10,039

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

709

 

Employee tax-related matters in foreign operations

 

 

 

1,223

 

 

 

 

1,921

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

459

 

 

 

 

418

 

Gain on the sale of land

 

 

 

 

 

 

 

(961

)

Adjusted Earnings from continuing operations

 

$

22,511

 

 

$

24,891

 

 

$

45,683

 

 

$

39,055

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Adjusted Diluted Earnings per Share
from Continuing Operations

 

 

 

 

 

 

 

 

 

 

GAAP diluted earnings per share from continuing
operations

 

$

1.22

 

 

$

0.56

 

 

$

2.01

 

 

$

0.56

 

Restructuring and severance costs at Aerospace

 

0.03

 

 

0.07

 

 

0.04

 

 

0.16

 

Costs associated with corporate development activities

 

0.20

 

 

 

 

0.29

 

 

0.02

 

Loss on sale of U.K. Tooling business

 

0.13

 

 

0.20

 

 

0.13

 

 

0.20

 

Costs from transition services agreement

 

0.10

 

 

 

 

0.13

 

 

 

Income from transition services agreement

 

(0.08

)

 

 

 

(0.10

)

 

 

Tax benefit from change in state tax laws

 

 

 

 

 

(0.07

)

 

 

Tax benefit of foreign derived income included in
discontinued operations

 

0.12

 

 

 

 

0.12

 

 

 

U.K. entity classification election for tax purposes

 

(0.92

)

 

 

 

 

(0.92

)

 

 

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

0.36

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

0.03

 

Employee tax-related matters in foreign operations

 

 

 

0.04

 

 

 

 

0.07

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

0.02

 

 

 

 

0.01

 

Gain on the sale of land

 

 

 

 

 

 

 

(0.03

)

Adjusted Diluted Earnings per Share from continuing
operations

 

$

0.80

 

 

$

0.89

 

 

$

1.63

 

 

$

1.38

 

Diluted weighted average shares outstanding

 

28,056

 

 

28,119

 

 

28,092

 

 

28,223

 

Adjusted
Net Sales from continuing operations and Adjusted Operating Income from continuing operations
- Adjusted
Net Sales from continuing operations is defined as net sales from continuing operations, less items not indicative of normal sales, such as revenue recorded related to the settlement of claims. Adjusted Operating Income from continuing operations is defined as operating income from continuing operations, less items that are not indicative of the operating performance of the Company for the period presented. These items are included in the reconciliation below. Management uses Adjusted
Net Sales from continuing operations and Adjusted Operating Income from continuing operations to evaluate performance period over period, to analyze underlying trends and to assess our performance relative to our competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance. The following table illustrates the calculation of Adjusted Operating Income from continuing operations to the Consolidated Financial Statements included in the Company's Form 10-K filed with the Securities and Exchange Commission on February 24, 2020.

Adjusted
Net Sales and Adjusted Operating Income from Continuing Operations

 

 

 

 

(In thousands) (unaudited)

 

 

 

 

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

AEROSPACE SEGMENT OPERATING INCOME:

 

 

 

 

 

 

 

 

Net Sales

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

GAAP Operating income - Aerospace segment

 

$

45,041

 

 

$

41,748

 

 

$

130,393

 

 

$

94,357

 

% of GAAP net sales

 

 

18.9

%

 

 

18.9

%

 

 

17.1

%

 

 

12.8

%

Restructuring and severance costs

 

 

78

 

 

 

2,305

 

 

 

631

 

 

 

7,016

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

 

10,039

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

 

709

 

Employee tax-related matters in foreign operations

 

 

 

 

1,761

 

 

 

 

 

3,040

 

Adjusted Operating Income - Aerospace segment

 

$

45,119

 

 

$

45,814

 

 

$

131,024

 

 

$

115,161

 

% of GAAP net sales

 

 

19.0

%

 

 

20.7

%

 

 

17.2

%

 

 

15.6

%

CORPORATE EXPENSE:

 

 

 

 

 

 

 

 

GAAP Corporate Expense

 

$

(26,576

)

 

$

(11,379

)

 

$

(73,006

)

 

$

(56,703

)

Restructuring and severance costs

 

 

927

 

 

 

337

 

 

 

927

 

 

 

337

 

Costs associated with corporate development activities

 

 

7,097

 

 

 

30

 

 

 

10,090

 

 

 

1,081

 

Costs from transition services agreement

 

 

3,519

 

 

 

 

 

4,673

 

 

 

Adjusted Corporate Expense

 

$

(15,033

)

 

$

(11,012

)

 

$

(57,316

)

 

$

(55,285

)

CONSOLIDATED OPERATING INCOME:

 

 

 

 

 

 

 

 

Net Sales from continuing operations

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

GAAP - Operating income from continuing operations

 

$

14,840

 

 

$

24,119

 

 

$

53,411

 

 

$

32,963

 

% of GAAP net sales

 

 

6.2

%

 

 

10.9

%

 

 

7.0

%

 

 

4.5

%

Restructuring and severance costs

 

 

1,005

 

 

 

2,642

 

 

 

1,558

 

 

 

7,353

 

Costs associated with corporate development activities

 

 

7,097

 

 

 

30

 

 

 

10,090

 

 

 

1,081

 

Costs from transition services agreement

 

 

3,519

 

 

 

 

 

4,673

 

 

 

Non-cash non-taxable intangible assets impairment
charge

 

 

 

 

 

 

 

 

10,039

 

Non-cash non-taxable write-off of inventory

 

 

 

 

 

 

 

 

709

 

Employee tax-related matters in foreign operations

 

 

 

 

1,761

 

 

 

 

 

3,040

 

Loss on sale of U.K. Tooling business

 

 

3,739

 

 

 

5,722

 

 

 

3,739

 

 

 

5,722

 

Loss on sale of assets and liabilities of Engineering
Services business

 

 

 

 

661

 

 

 

 

 

661

 

Gain on sale of land

 

 

 

 

 

 

 

 

(1,520

)

Adjusted Operating Income

 

$

30,200

 

 

$

34,935

 

 

$

73,471

 

 

$

60,048

 

% of GAAP net sales

 

 

12.7

%

 

 

15.8

%

 

 

9.6

%

 

 

8.2

%

Outlook - Adjusted
Net Sales and Adjusted Operating Income from Continuing Operations

(In millions) (unaudited)

 

 

 

 

 

 

2020 Outlook

 

 

Low

 

High

OPERATING INCOME FROM CONTINUING OPERATIONS

 

 

 

 

Net Sales from Continuing Operations

 

$

860.0

 

 

$

880.0

 

GAAP - Operating income from Continuing Operations

 

$

43.4

 

 

$

59.0

 

Operating margin from Continuing Operations

 

5.0

%

 

6.7

%

Adjustments

 

 

 

 

Bal Seal Purchase Accounting - Inventory Step-up

 

$

9.2

 

 

$

9.2

 

Bal Seal Purchase Accounting - Compensation Expense

 

22.8

 

 

22.8

 

Cost associated with corporate development activities

 

1.5

 

 

1.5

 

Costs from transition services agreement

 

8.8

 

 

8.8

 

Adjusted Operating Income from Continuing Operations

 

$

85.7

 

 

$

101.3

 

Operating margin from continuing operations, adjusted

 

10.0

%

 

11.5

%

FORWARD-LOOKING STATEMENTS

This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) the possibility that we may be unable to find appropriate reinvestment opportunities for the proceeds from the sale of our former Distribution business; (ii) risks related to Kaman's performance of its obligations under the transition services agreement entered into in connection with the sale of our former Distribution business and disruption of management time from ongoing business operations relating thereto; (iii) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; (iv) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional actions or automatic sequestration); (v) changes in geopolitical conditions in countries where the Company does or intends to do business; (vi) the successful conclusion of competitions for government programs (including new, follow-on and successor programs) and thereafter successful contract negotiations with government authorities (both foreign and domestic) for the terms and conditions of the programs; (vii) the timely receipt of any necessary export approvals and/or other licenses or authorizations from the USG; (viii) timely satisfaction or fulfillment of material contractual conditions precedents in customer purchase orders, contracts, or similar arrangements; (ix) the existence of standard government contract provisions permitting renegotiation of terms and termination for the convenience of the government; (x) the successful resolution of government inquiries or investigations relating to our businesses and programs; (xi) risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs; (xii) potential difficulties associated with variable acceptance test results, given sensitive production materials and extreme test parameters; (xiii) the receipt and successful execution of production orders under the Company's existing USG JPF contract, including the exercise of all contract options and receipt of orders from allied militaries, but excluding any next generation programmable fuze programs, as all have been assumed in connection with goodwill impairment evaluations; (xiv) the continued support of the existing K-MAX® helicopter fleet, including sale of existing K-MAX® spare parts inventory and the receipt of orders for new aircraft sufficient to recover our investments in the K-MAX® production line; (xv) the accuracy of current cost estimates associated with environmental remediation activities; (xvi) the profitable integration of acquired businesses into the Company's operations; (xvii) the ability to recover from cyber-based or other security attacks, information technology failures or other disruptions; (xviii) changes in supplier sales or vendor incentive policies; (xix) the ability of our suppliers to satisfy their performance obligations; (xx) the effects of price increases or decreases; (xxi) the effects of pension regulations, pension plan assumptions, pension plan asset performance, future contributions and the pension freeze, including the ultimate determination of the USG's share of any pension curtailment adjustment calculated in accordance with CAS 413; (xxii) future levels of indebtedness and capital expenditures; (xxiii) the continued availability of raw materials and other commodities in adequate supplies and the effect of increased costs for such items; (xxiv) the effects of currency exchange rates and foreign competition on future operations; (xxv) changes in laws and regulations, taxes, interest rates, inflation rates and general business conditions; (xxvi) the effects, if any, of the United Kingdom's exit from the European Union; (xxvii) future repurchases and/or issuances of common stock; (xxviii) the occurrence of unanticipated restructuring costs or the failure to realize anticipated savings or benefits from past or future expense reduction actions; (xxix) the ability to recruit and retain skilled employees; and (xxx) other risks and uncertainties set forth herein and in our 2019 Form 10-K.

Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

KAMAN CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts) (unaudited)

 

 

For the Three Months Ended

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

 

December 31,
2019

 

December 31,
2018

Net sales

 

$

237,792

 

 

$

220,859

 

 

$

761,608

 

 

$

735,994

 

Cost of sales

 

165,230

 

 

147,851

 

 

520,803

 

 

508,677

 

Gross profit

 

72,562

 

 

73,008

 

 

240,805

 

 

227,317

 

Selling, general and administrative expenses

 

49,573

 

 

39,997

 

 

177,187

 

 

172,271

 

Other intangible assets impairment (Note 12)

 

 

 

 

 

 

 

10,039

 

Costs from transition services agreement (Note 3)

 

3,519

 

 

 

 

4,673

 

 

 

Restructuring costs (Note 5)

 

1,005

 

 

2,642

 

 

1,558

 

 

7,353

 

Loss on sale of business (Note 5)

 

3,739

 

 

5,722

 

 

3,739

 

 

5,722

 

Net loss (gain) on sale of assets

 

(114

)

 

528

 

 

237

 

 

(1,031

)

Operating income

 

14,840

 

 

24,119

 

 

53,411

 

 

32,963

 

Interest expense, net

 

2,607

 

 

4,639

 

 

17,202

 

 

20,046

 

Non-service pension and post retirement benefit
income

 

(98

)

 

(3,084

)

 

(396

)

 

(12,127

)

Income from transition services agreement (Note 3)

 

(2,729

)

 

 

 

(3,673

)

 

 

Other expense (income), net

 

58

 

 

49

 

 

(309

)

 

(92

)

Earnings from continuing operations before income
taxes

 

15,002

 

 

22,515

 

 

40,587

 

 

25,136

 

Income tax (benefit) expense

 

(19,103

)

 

6,883

 

 

(15,859

)

 

9,259

 

Earnings from continuing operations, net of tax

 

34,105

 

 

15,632

 

 

56,446

 

 

15,877

 

Earnings from discontinued operations before gain on
disposal, net of tax

 

3,787

 

 

7,945

 

 

29,027

 

 

38,292

 

Gain on disposal of discontinued operations, net of tax

 

1,570

 

 

 

 

124,356

 

 

 

Total earnings from discontinued operations, net of
tax

 

5,357

 

 

7,945

 

 

153,383

 

 

38,292

 

Net earnings

 

$

39,462

 

 

$

23,577

 

 

$

209,829

 

 

$

54,169

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

Basic earnings per share from continuing
operations

 

$

1.22

 

 

$

0.56

 

 

$

2.02

 

 

$

0.57

 

Basic earnings per share from discontinued
operations

 

0.19

 

 

0.28

 

 

5.49

 

 

1.37

 

Basic earnings per share

 

$

1.41

 

 

$

0.84

 

 

$

7.51

 

 

$

1.94

 

Diluted earnings per share from continuing
operations

 

$

1.22

 

 

$

0.56

 

 

$

2.01

 

 

$

0.56

 

Diluted earnings per share from discontinued
operations

 

0.19

 

0.28

 

5.46

 

 

1.36

 

Diluted earnings per share

 

$

1.41

 

 

$

0.84

 

 

$

7.47

 

 

$

1.92

 

Average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

27,922

 

 

27,951

 

 

27,936

 

 

27,945

 

Diluted

 

28,056

 

 

28,119

 

 

28,092

 

 

28,223

 

KAMAN CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share and per share amounts) (unaudited)

 

 

December 31, 2019

 

December 31, 2018

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

471,540

 

 

$

25,895

 

Accounts receivable, net

 

156,492

 

 

149,338

 

Contract assets

 

121,614

 

 

99,261

 

Contract costs, current portion

 

6,052

 

 

5,993

 

Inventories

 

156,353

 

 

131,569

 

Income tax refunds receivable

 

8,069

 

 

1,752

 

Assets held for sale, current portion

 

 

 

351,261

 

Other current assets

 

16,368

 

 

8,036

 

Total current assets

 

936,488

 

 

773,105

 

Property, plant and equipment, net of accumulated depreciation of $210,549
and $192,285, respectively

 

140,450

 

 

137,112

 

Operating right-of-use asset, net

 

15,159

 

 

 

Goodwill

 

195,314

 

 

196,161

 

Other intangible assets, net

 

53,439

 

 

58,567

 

Deferred income taxes

 

35,240

 

 

38,040

 

Contract costs, noncurrent portion

 

6,099

 

 

10,666

 

Assets held for sale, noncurrent portion

 

 

 

229,238

 

Other assets

 

36,754

 

 

31,173

 

Total assets

 

$

1,418,943

 

 

$

1,474,062

 

Liabilities and Shareholders’ Equity

 

 

 

 

Current liabilities:

 

 

 

 

Current portion of long-term debt, net of debt issuance costs

 

$

 

 

$

9,375

 

Accounts payable – trade

 

70,884

 

 

56,826

 

Accrued salaries and wages

 

43,220

 

 

32,795

 

Contract liabilities, current portion

 

42,942

 

 

28,865

 

Operating lease liabilities, current portion

 

4,306

 

 

 

Income taxes payable

 

4,722

 

 

139

 

Liabilities held for sale, current portion

 

 

 

131,047

 

Other current liabilities

 

37,918

 

 

39,429

 

Total current liabilities

 

203,992

 

 

298,476

 

Long-term debt, excluding current portion, net of debt issuance costs

 

181,622

 

 

284,256

 

Deferred income taxes

 

6,994

 

 

7,146

 

Underfunded pension

 

97,246

 

 

104,988

 

Contract liabilities, noncurrent portion

 

37,855

 

 

78,562

 

Operating lease liabilities, noncurrent portion

 

11,617

 

 

 

Liabilities held for sale, noncurrent portion

 

 

 

15,602

 

Other long-term liabilities

 

56,415

 

 

51,875

 

Commitments and contingencies (Note 19)

 

 

 

 

Shareholders’ equity:

 

 

 

 

Preferred stock, $1 par value, 200,000 shares authorized; none outstanding

 

 

 

 

Common stock, $1 par value, 50,000,000 shares authorized; voting;
30,058,455 and 29,544,714 shares issued, respectively

 

30,058

 

 

29,545

 

Additional paid-in capital

 

228,153

 

 

200,474

 

Retained earnings

 

820,666

 

 

610,103

 

Accumulated other comprehensive income (loss)

 

(150,893

)

 

(134,898

)

Less 2,219,332 and 1,672,917 shares of common stock, respectively, held
in treasury, at cost

 

(104,782

)

 

(72,067

)

Total shareholders’ equity

 

823,202

 

 

633,157

 

Total liabilities and shareholders’ equity

 

$

1,418,943

 

 

$

1,474,062

 

KAMAN CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands) (unaudited)

 

 

 

For the Twelve Months Ended

 

 

December 31,
2019

 

December 31,
2018

Cash flows from operating activities:

 

 

 

 

Net earnings

 

$

209,829

 

 

$

54,169

 

Less: Total earnings from discontinued operations, net of tax

 

153,383

 

 

38,292

 

Earnings from continuing operations, net of tax

 

56,446

 

 

15,877

 

Adjustments to reconcile earnings from continuing operations, net of tax to net cash
provided by operating activities:

 

 

 

 

Depreciation and amortization

 

25,854

 

 

27,875

 

Amortization of debt issuance costs

 

1,996

 

 

1,806

 

Accretion of convertible notes discount

 

2,760

 

 

2,596

 

Provision for doubtful accounts

 

788

 

 

767

 

Loss on sale of business

 

3,971

 

 

5,722

 

Net loss (gain) on sale of assets

 

237

 

 

(1,031

)

Other intangible assets impairment

 

 

 

10,039

 

Net loss (gain) on derivative instruments

 

302

 

 

829

 

Stock compensation expense

 

4,669

 

 

5,484

 

Non-cash consideration received for aircraft sale

 

(3,100

)

 

 

Deferred income taxes

 

182

 

 

7,834

 

Changes in assets and liabilities, excluding effects of acquisitions/divestitures:

 

 

 

 

Accounts receivable

 

(8,173

)

 

(6,020

)

Contract assets

 

(21,994

)

 

(24,294

)

Contract costs

 

4,506

 

 

(5,834

)

Inventories

 

(25,129

)

 

7,135

 

Income tax refunds receivable

 

(6,296

)

 

1,136

 

Operating right-of-use assets

 

3,390

 

 

 

Other assets

 

(6,108

)

 

(2,944

)

Accounts payable - trade

 

14,034

 

 

10,807

 

Contract liabilities

 

(26,638

)

 

96,430

 

Operating lease liabilities

 

(3,423

)

 

 

Other current liabilities

 

6,085

 

 

(374

)

Income taxes payable

 

7,888

 

 

(2,393

)

Pension liabilities

 

4,170

 

 

(38,179

)

Other long-term liabilities

 

6,071

 

 

5,446

 

Net cash provided by operating activities from continuing operations

 

42,488

 

 

118,714

 

Net cash (used in) provided by operating activities of discontinued operations

 

(50,288

)

 

43,654

 

Net cash (used in) provided by operating activities

 

(7,800

)

 

162,368

 

Cash flows from investing activities:

 

 

 

 

Proceeds from sale of assets

 

196

 

 

2,138

 

Proceeds from sale of discontinued operations

 

655,030

 

 

 

Expenditures for property, plant & equipment

 

(22,447

)

 

(21,504

)

Other, net

 

(4,463

)

 

(3,172

)

Net cash provided by (used in) investing activities of continuing operations

 

628,316

 

 

(22,538

)

Net cash used in investing activities of discontinued operations

 

(9,838

)

 

(7,423

)

Net cash provided by (used in) investing activities

 

618,478

 

 

(29,961

)

Cash flows from financing activities:

 

 

 

 

Net repayments under revolving credit agreements

 

(38,500

)

 

(98,087

)

Debt repayment

 

(76,875

)

 

(7,500

)

Repayment of convertible notes

 

(500

)

 

 

Net change in bank overdraft

 

886

 

 

(279

)

Proceeds from exercise of employee stock awards

 

19,676

 

 

7,351

 

Purchase of treasury shares

 

(30,060

)

 

(19,278

)

Dividends paid

 

(22,343

)

 

(22,349

)

Debt and equity issuance costs

 

(3,584

)

 

 

Other

 

(1,413

)

 

(1,003

)

Net cash used in financing activities of continuing operations

 

(152,713

)

 

(141,145

)

Net cash provided by (used in) financing activities of discontinued operations

 

7,967

 

 

(217

)

Net cash used in financing activities

 

(144,746

)

 

(141,362

)

Net increase (decrease) in cash and cash equivalents

 

465,932

 

 

(8,955

)

Cash and cash equivalents of discontinued operations

 

(21,834

)

 

(1,816

)

Effect of exchange rate changes on cash and cash equivalents

 

(269

)

 

(238

)

Cash and cash equivalents at beginning of period

 

27,711

 

 

36,904

 

Cash and cash equivalents at end of period

 

$

471,540

 

 

$

25,895

 

 

James CooganV.P., Investor Relations and Business Development
(860) 243-6342
James.Coogan@kaman.com

Source: Kaman Corp.

James Coogan
V.P., Investor Relations and Business Development
(860) 243-6342
James.Coogan@kaman.com